Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
OSTEO-TREAT from Duffel, company number BE0896487757, closed financial year 2025 with a result of € 25,453 after tax. For that financial year OSTEO-TREAT recorded a gross margin of € 48,693 and equity of € 339,148. Compared with financial year 2024, the result moved from € 36,232 to € 25,453. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ 339,148
▲ 8% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 25,453
▼ 30% vs 2024
Profit after tax over the fiscal year.
€ 279,515
▲ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 332,948.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 9,492
▼ 34% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,800
▲ 153% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 69,620 | € 70,884 | € 60,031 | € 48,693 | ▼ 19% |
| Profit after taxes | € 43,501 | € 44,203 | € 36,232 | € 25,453 | ▼ 30% |
| Equity | € 233,260 | € 277,463 | € 313,695 | € 339,148 | ▲ 8% |
| Total debts | € 4,561 | € 5,567 | € 10,469 | € 3,168 | ▼ 70% |
| Cash | € 213,898 | € 250,985 | € 263,920 | € 279,515 | ▲ 6% |
| Land & buildings | € 8,064 | € 11,988 | € 18,008 | € 14,962 | ▼ 17% |
| Retained profit | € 227,060 | € 271,263 | € 307,495 | € 332,948 | ▲ 8% |
| Dividend | € 23,590 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 237,820 | € 283,030 | € 324,164 | € 342,316 | ▲ 6% |
Key figures of OSTEO-TREAT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to OSTEO-TREAT?
What happened at OSTEO-TREAT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 25,453 (▼ 30% vs 2024). Source: NBB ↗
- Ingrid Van Elsen became a director. NBB
- New establishment in Duffel. KBO
- Start of the company according to the CBE. KBO
In short
From € 43,501 profit in 2022 to € 25,453 profit in 2025.
Paid € 75,701 in corporate taxes since 2022.
Best year ever: 2023, with € 44,203 profit.
Paid out € 23,590 in dividends to the owners in total.
Management
Behind OSTEO-TREAT is Ingrid Van Elsen. It owns 42% of Theradix itself.
Directors
According to the 2025 annual accounts
Ingrid Van Elsen
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Emiel van Hammestraat 2 box B
2570 Duffel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
one.com Mail
Hosting
ONECOM, DK
Website info
Features
Security
Network
Details
- Company number
- 0896.487.757
- VAT number
- BE 0896.487.757
- Registered office
- Emiel van Hammestraat 2 bus B, 2570 Duffel
- Names & denominations
- OSTEO-TREAT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 March 2008
- Peppol
- Not registered